Phreesia, Inc. (NYSE:PHR) SVP Sells $321,103.80 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,685 shares of the firm’s stock in a transaction on Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $321,103.80. Following the completion of the transaction, the senior vice president now directly owns 231,271 shares of the company’s stock, valued at approximately $6,355,327.08. This trade represents a 4.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

David Linetsky also recently made the following trade(s):

• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $25.38, for a total transaction of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The stock was sold at an average price of $24.88, for a total transaction of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The stock was sold at an average price of $24.85, for a total value of $294,547.05.

Phreesia Trading Down 1.7 %

Shares of NYSE PHR traded down $0.49 during trading hours on Wednesday, reaching $28.81. The stock had a trading volume of 384,950 shares, compared to its average volume of 392,842. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.90. The firm has a market cap of $1.67 billion, a price-to-earnings ratio of -19.60 and a beta of 0.94. The business’s fifty day moving average price is $24.57 and its two-hundred day moving average price is $23.20. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same period in the prior year, the business earned ($0.58) EPS. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. Analysts expect that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Robert W. Baird lowered their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research note on Wednesday, December 11th. Royal Bank of Canada upgraded Phreesia from a “sector perform” rating to an “outperform” rating and raised their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Friday, January 10th. JMP Securities restated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Finally, Citigroup increased their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Thirteen analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $31.15.

Institutional Investors Weigh In On Phreesia

Several large investors have recently modified their holdings of the business. R Squared Ltd purchased a new position in Phreesia during the fourth quarter valued at approximately $30,000. International Assets Investment Management LLC increased its holdings in shares of Phreesia by 2,179.7% in the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares during the period. XTX Topco Ltd bought a new position in shares of Phreesia in the 3rd quarter worth $247,000. Hsbc Holdings PLC purchased a new stake in shares of Phreesia during the 2nd quarter worth $301,000. Finally, Intech Investment Management LLC purchased a new position in Phreesia in the third quarter valued at about $316,000. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.